US approves promising preventive HIV treatment
The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injvirection, for preventing HIV infection in adults and adolescents at high risk of contracting the deadly virus. Lenacapavir proved nearly 100% effective at preventing HIV in large trials last year, raising new hope of interrupting transmission of the virus that infects 1.3 million people a year.
Related Articles
Live Updates: Trump Will Decide on Iran Attack ‘Within the Next Two Weeks,’ White House Says
European officials, who have been effectively sidelined in the war between Israel...
‘Two Weeks’ Is Trump’s Favorite Unit of Time
“Two weeks” is one of President Trump’s favorite units of time. It...
Iranian Missile Hits Israeli Hospital as Trump Appears to Put Off U.S. Action
President Trump said he would decide within two weeks whether the United...
Hurricane Erick Makes Landfall In Mexico
On Thursday morning, Hurricane Erick hit Mexico’s southern coastline as a Category...
Leave a comment